SNDL Inc.

Good morning and welcome to SNDL's third quarter 2025 financial results conference call. This morning, SNDL issued a press release announcing their financial results for the 2025 third quarter ended on September 30th, 2025. This press release is available on the company's website at SNDL.com and filed on EDGAR and CDER as well. The webcast replay of the conference will also be available on the SNDL S&DL has also posted a supplemental investor presentation in addition to the conference call presentation we will be reviewing today on its S&DL.com website. Presenting on this morning's call, we have Zach George, Chief Executive Officer, and Alberto Pereiro, Chief Financial Officer. Before we start, I would like to remind investors that certain matters discussed in today's conference call or answers that may be given to questions could constitute forward-looking statements. Actual results could differ materially from those anticipated. Risk factors that could affect results are detailed in the company's financial reports and other public filings that are made available on CDER and EDGAR. Additionally, all financial figures mentioned are in Canadian dollars unless otherwise indicated. We will now make prepared remarks and then we'll move to analyst questions. I would now like to turn the call over to Zach George. Please go ahead.

Welcome to S&DL's third quarter 2025 financial and operational results conference call. The third quarter of 2025 marks another milestone for S&DL as we report record quarterly free cash flow and for the first time in our history, positive cumulative free cash flow for the first nine months of the year.

We also continue to report sustained double-digit revenue growth in our combined cannabis segment, underscoring the strength of our ongoing operational and profitability improvements. Beyond our ability to generate cash, which in our view is the ultimate measure of a business's fundamentals, We are also seeing numerous bright spots in our income statement. These include robust growth in our cannabis segments, margin expansion across our retail operations, G&A expenses. Collectively, these factors translate into continuous improvements in our financial performance. Despite our progress in operations, competitive position, this quarter's P&L growth reflects the impact of $11.9 million in unfavorable non-cash items.

by increases in our stock valuation as well as inventory and fixed asset impairments, resulting in a reported offering loss of $11 million. For those who are unfamiliar, our unvested long-term incentive equity grants show up as a liability on our balance sheet. So when our stock price increases, we have to take a negative charge to operating income in order to reflect the increased value of that liability. These non-cash items and the volatility inherent to our industry should not overshadow the undeniable operational improvements we have achieved. We also continue to leverage the strategic advantage provided by our strong balance sheet with no debt and over $240 million in unrestricted cash as we build a resilient, growth-oriented, and profitable business. To this last point, during the third quarter, we continued to support the regulatory review process in Ontario, which is the final step before closing the acquisition of 32 1CM cannabis stores. We also accelerated our investment pace to support the opening of five new cannabis stores and two new Wine & Beyond stores during the fourth quarter. Additionally, we completed the ramp-up of our Atholville cultivation facility to support international growth, and we are now making further investments in its infrastructure. Last but not least, beyond strengthening our competitive position in Canada, the company continues to work toward resolving the ongoing litigation required to complete the Sunstream restructurings. These restructurings are expected to provide shareholders with exposure to dynamic medical markets, including Florida and Texas. I'll pass the call to Alberto now for more insights on our third quarter financial performance. Thank you, Zach.

I want to remind everyone that the amounts discussed today are denominated in Canadian dollars unless otherwise stated. Certain figures referred to in this call are non-GAAP and non-IFRS measures. For definitions of these measures, please refer to SMDL's management discussion and analysis document. Our third quarter financial results represent another step forward in profitability, particularly in terms of free cash flow generation. Net revenue for the third quarter of 2025 reached $244 million, reflecting a 3.1% increase compared to Q3 of last year. This growth was driven by our cannabis segments, while the liquor segment continues to navigate market headwinds. Gross profit of $64.9 million. represents a 1.2 million increase, or 1.9% growth year-over-year, despite being impacted by 3.9 million in non-cast inventory-related adjustments within cannabis operations. These inventory adjustments reduce gross margin by 160 basis points, more than offsetting the strong margin expansion in both liquor and cannabis retail segments. As a result, Consolidated gross margin declined 30 basis points compared to the prior year. Operating income was affected by non-cast adjustments totaling $11.9 million. In addition to the $3.9 million inventory adjustment mentioned earlier, the 121% share price increase during the third quarter triggered a $6.8 million increase in share-based compensation liabilities. Finally, we recorded a net of $1.6 million fixed asset investment, mostly driven by the idle skeleton facility. These three factors fully explain the reported operating loss of $11 million. When excluding a $1.5 million restructuring charge, adjusted operating income ended at a loss of $9.5 million. Yet this represents a $7.1 million improvement of 42.7% compared to last year. Free cash flow is the main highlight of the quarter, with a positive $16.7 million. In addition to the $7.5 million improvement compared to the same period last year, These strong Q3 results enable us, for the first time in our history, to achieve positive cumulative free cash flow for the first nine months of the year, totaling $7.7 million year-to-date. When reviewing our four-year historical performance, we continue to demonstrate a clear upward trajectory, reflecting our sustained focus on growth and improved operational efficiencies. Additionally, we can observe the seasonality of free cash flow within the first and second half of the year, with a consistent upward trend over time. When analyzing the contributions from each segment across our main financial KPIs, we can clearly see that net revenue growth was driven by our cannabis segments, partly offset by legal retail. The revenue elimination for cannabis is related to the sales from the cannabis operations segment into our own retail. As in previous quarters, this elimination is increasing as a result of our cannabis business growth. Adjusted operating income shows a solid improvement compared to the prior year, although there is some noise related to non-cast adjustments in both periods. Liquor retail posted a small decline of $0.6 million as gross margin and SDNA improvements were offset by revenue declines and the lapping of a $1.2 million favorable fixed asset impairment reversal recorded in 2024. Cannabis retail delivered strong operating income growth driven by revenue gains, gross margin expansion, and SDNA increase. Additionally, this quarter included a $1 million reversal for asset impairments recorded several years ago. Cannabis operations reported negative operating growth, primarily due by the $3.9 million inventory valuation adjustments and the $2.7 million fixed asset impairment related to the Idaho Stellar Drone Facility. The investment segment shows significant favorability year over year, as last year included an unfavorable valuation adjustment from the Sunstream investment portfolio. Finally, despite meaningful cost reductions in the corporate segment, the $6.8 million increase in share-based compensation, triggered by the 121% rise in our share price in the third quarter, resulted in a $2.2 million unfavorable movement year over year. Clearly, there are numerous atypical adjustments impacting the third quarter in both years. When we strip away this noise, the underlying improvement in operating income becomes evident. Both the third quarter and the year-to-date free cash flow results are the key highlights. each representing historic records for the company. In the third quarter, the negative income of $13.3 million was driven by the different non-cast adjustments previously mentioned, which leads to the high amount of $13.8 million in non-cast add-backs. Inventory and other working capital follow the regular seasonality, as investments in the first half of the year started being offset as of the third quarter. We're also seeing the higher amount of capex and lease payments in the third quarter compared to the previous two quarters, driven by the incremental capital investments for the anticipated store-opening in the fourth quarter. These strong Q3 free cash flow results is allowing us to report for the first time in our history positive cumulative free cash flow in the first nine months of the year, with a total of $7.7 million. Looking closer at the three operating segments, starting with legal retail, we see that the segment delivered net revenue of $139.4 million in the third quarter. a 3.6% year-over-year decline as it continues to face market headwinds. Gross profits of $36.7 million represents a modest reduction of $0.2 million compared to the prior year, as the revenue decline was almost fully offset by 80 basis point improvement in gross margin, which reached 26.3%, a new historic record for the segment. Operating income came in at $11.2 million, a decrease of $0.6 million compared to last year. While the record gross margin and further reduction in SD&A spending provided support, these gains were offset by the lapping of $1.2 million in fixed asset impairment reversals recorded in 2024. Cannabis retail delivered outstanding results in the third quarter. Net revenue of $85 million represents a new record for the segment, supported by a 4.8% year-over-year growth, driven primarily by a 3.6% increase in same-store sales. Gross profit of $22.5 million is also a historic high for the segment, reflecting an 8.5% increase compared to last year, supported by a 90 basis points improvement in gross margins. Finally, both operating income and adjusted operating income reach new records for the segment, driven by revenue growth, margin expansion, and SD&A optimization. Operating income of $9.1 million, more than double compared to last year, further benefiting from a $1 million fixed asset impairment reversals recorded in the quarter. Our cannabis operation segment delivered mixed results as a result of non-cast adjustments impacting the third quarter, masking the underlying improvements. Net revenue for the third quarter of 2025 was $37.4 million, also a new record for the segment, reflecting a $12.4 million or 50% growth compared to the prior year. This growth was driven by edibles following the acquisition of INDIVA in the fourth quarter of 2024, as well as the accelerating international sales that reached 4.2 million in the quarter. Growth profit was impacted by 3.9 million inventory write-offs and valuation adjustments primarily related to the cultivation ramp-up at our asphalt bill facility. Growth margin ended up at 13.4% in the quarter, as the inventory adjustments had a negative impact of 10.4 percentage points to the margin of the segment. Finally, adjusted operating income also reflects a $2.7 million fixed asset impairment related to the Stellarton idle facility. The total of $6.6 million in unfavorable inventory and fixed asset non-cast adjustments resulted in the negative $4.8 million adjusted operating income. Over to you, Zach, for additional comments related to our strategic priorities.

Looking at the progress we've made towards our three strategic priorities, growth, profitability, and people, there are several highlights I'd like to point out.

Let's start with growth.

Our cannabis retail segment continues to outperform the market, achieving 3.6% same-store sales growth in the third quarter and contributing to an additional 12 basis point gain in market share. Despite softness in the liquor market, our Wine & Beyond banner continues to demonstrate strength with 2.9% same-store sales growth, supported by double-digit growth in private label sales. As mentioned in previous calls, we have accelerated organic capital investments in new store expansion. In addition to the two cannabis stores opened during the third quarter, We anticipate opening five new cannabis stores and two new Wine & Beyond stores in the fourth quarter. It is also encouraging to see strong 50% revenue growth from our cannabis operations segment, driven by market leadership in edibles following the acquisition of Endiva in the fourth quarter of last year, as well as continued growth in international sales, which reached 4.2 million in the third quarter. Shifting to profitability, the most significant highlight is the generation of $17 million in free cash flow during the quarter, enabling us to achieve positive year-to-date free cash flow of $7.7 million at the end of the third quarter for the very first time in our history. This was accomplished through revenue and margin expansion, coupled with working capital optimization despite incremental CapEx investments, to fund future growth. While adjusted offering income remains negative due to the previously mentioned non-cash items reflected in the quarter, it did grow by 43% compared to the prior year, supported by revenue growth, retail margin expansion, and reductions in G&A costs. On that point, G&A expenses in the third quarter were $4 million lower than last year. as our $5 million of productivity savings more than offset inflationary pressures. Additionally, data licensing revenue contributed $4.6 million in the quarter, providing further support for gross margin expansion. Foundational to all of these improvements is our people's strategic priority. During the third quarter, we continued to enhance the deployment of talent cards, and development conversations, a key step in our strategic talent review process. We also launched a recruitment efficiencies project to streamline hiring and improve the experience for recruiters, hiring managers, and candidates through automated workflows. Additionally, we introduced a monthly leadership development series, a new networking forum where leaders share personal and professional experiences and discuss our strategic priorities. As we focus on driving strong execution in the fourth quarter and a strong finish to the year, we are also encouraged by the many opportunities and execution plans our teams are developing for 2026, taking us step-by-step closer to our ambition to become a global cannabis leader. Once again, I'd like to thank our entire team for their contributions and our shareholders for their continued trust.

I will now hand the call back to the operator for the analyst Q&A session. Thank you.

And we will now begin our analyst Q&A session. In order to join the Q&A queue, please press star 1 on your telephone. You will then hear an automated message advising that your hand is raised. Also, if you are on speakerphone, please pick up the handset before pressing any keys. To answer our question, press star 11 again. One moment while we can pull the Q&A roster.

And the first question today will be coming from the line of Aaron Gray of Alliance Global Partners.

Please go ahead.

Hi, good morning, and thank you very much for the questions, and I see some more of the cash flow generation. First question for me, you know, just want to kind of strip out, you know, some of the one-offs, make sure we have a good understanding of how best to think about the business going forward. So particularly for cannabis operations, you know, included the write-offs for inventory, you know, within that. So just want to clarify there from the prepared remarks, Was it only the 3.9 inventory in the gross margin and the 1.6 million fixed asset that's SG&A and not in gross margin? So I want to clarify that point. And then secondly, you know, how best to think about the gross margin specifically for the cannabis operations, you know, going forward? You know, if both of those are added back, yeah. you back to that 29% gross margin from prior quarter. If just inventory, it gets you more to the mid-20s, so just want to get a better understanding of how to think about that on a go-forward basis. Thank you.

Good morning, and thank you for the question. So, yes, I confirmed the $3.9 million of inventory adjustments that obviously is impacting gross profit. And it has an impact of about 10.6 percentage points in the margin of the segment. The other one-time adjustment that we saw in the quarter is the stericum facility impairment. It's a $2.7 million charge. That happened below gross profit. So it's part of operating income, but not reflecting the gross margin. So the total of those two things obviously are impacting operating income, but the only impact to gross profit is based on the inventory adjustment. Without those adjustments, we would have been at around 25% margin. in the segment, which is what we're expecting. We have seen around about that number in the last couple of quarters, and we're expecting that to be the low end of the range for the future.

Okay, great. Thanks for that, Kyler. The provincial board saw some nice growth both on a quarter-over-quarter and year-over-year basis. Any specific drivers there? And anything to think about in terms of the mix within that shipment timing for how we think about that line segment going forward? Because it does seem like that growth outpaced some of what we're seeing from the third-party POI data.

Yes, indeed, we're seeing the same softness overall in the sales to the provincial boards from Canada's operations. We know that it's not driven by our own segment as we continue to gain momentum there and we continue to see growth, but we have seen some softness in third-party retail. Obviously, we don't have full visibility to the elementary numbers of the provincial boards, So an element of this slowdown could be as well driven by that. But overall, as we have seen over the last couple of quarters, a slowdown in third-party retail that we're working on, obviously trying to create some additional momentum. And with the changes in new products and innovation, we believe that we're going to be regaining momentum in there.

And just to add to Alberto's comments, good morning. Thanks for the questions. We are seeing great progress in specific categories, including edibles, free roll, and vape. And so that's enabled us to keep a great pace relative to the broader market.

Okay, great. Thanks for that.

Last one, you've been increasing your efforts internationally. I think you said 4.2 in the quarter. So how best to think about international sales going forward? How big of a part of the business do you feel like that could be within the next 12 to 18 months?

It does keep to continue to gain momentum. We have been increasing quarterly over quarter since the beginning of the year. We have a strong demand. We have a lot of port disorders for the fourth quarter as well. We are bullish as well with the outlook for 2026. A lot of our international partners, they are exploring options to continue increasing portages from us. They are struggling with reliability of supply from some of their other partners that they have, and they have been very pleased with our performance so far. So, yeah, we believe and we're anticipating that that number will continue growing in the future.

Thank you very much. It's worth mentioning that we are continuing to ramp production at our applicable New Brunswick facility. the benefits from extremely attractive relative power pricing. And so we should see monthly production based on our targets north of 15,000 kilograms a month in 2026. And so we expect the bulk of that biomass to be directed at international markets. And there's a number of other, both 2.0 and other growth opportunities that we're looking at.

Okay, great. Next caller, I'll go and jump back into the queue.

Thank you. As a reminder, if you would like to ask a question, please press star 11 on your telephone. One moment for the next question. Our next question will be coming from the line of Federico Gomez of ATB Capital Markets. Your line is open.

Good morning. Thanks for taking my questions. First question, just on the 1CM transaction that still hasn't been closed, you said you're waiting for approval in Ontario. So is there anything specific that's been an issue with that approval? I'm just thinking about the previous history here back when you had the Innova transaction, and I believe that there was a holdup there in Ontario. So just any comments on that?

Thanks for the question, Fred, and good morning. We don't have any additional information to share. We thought this would be – the review would be completed late October. It's early November. There are a number of retail licenses, both applications that have been submitted by affiliated entities as well as third parties that are still moving through the pipeline in Ontario.

So we'll update the market as soon as we have greater clarity. Thank you.

And then the second question, just on cannabis retail, I guess we saw a good same-star sales growth this quarter again, you know, record numbers and gross profit, celebrating income as well. Just broader comments about what you're seeing in that market right now. Are you seeing opportunities to increase prices and margins? Are you seeing a good pipeline of M&A? Or is it going to be concentrated more organic growth, obviously excluding the 1CM transaction? Just some broader color on the outlook for Canada's retail in Canada right now. Thanks.

It's a great question. We are seeing maturity. It's really a province by province assessment. We've seen extreme saturation start to settle in Alberta. And as you well know, Federico, Alberta was one of the quickest provinces out of the gate in terms of its pace of door count growth. You're seeing signs emerging of maturity in markets like Ontario as well, although we still think there's opportunity there. And I think that the days of easy kind of double-digit, high single-digit, same-store sales growth upon opening locations and managing discount retail strategy are going to be in the rearview very quickly. Execution on the floor and owning a consumer relationship with a very convenient and attractive experience for customers is critical at this point. So, we are very much focused on our consumer and owning that relationship.

If you compare to the same period of last year, you have probably noticed in the third quarter that our same-store sales have slowed down somewhat compared to the first half of the year. On the other side, we're seeing a significant increase in growth margins. The main reason last year for the third quarter, we started to run more aggressive promotional activities that obviously pushed a little bit the top line, but tempered the gross margin. As we are lapping that strong promo activity this year, we're seeing margin progression. Obviously, somehow a little bit of a slowdown on some sales revenue growth. It will probably be a similar dynamic in the fourth quarter, but we still see some... We see margins somewhat stabilizing for the long run. There's always an opportunity to increase efficiencies and manage to mix a little bit better and gain... marginally on the gross margin. But clearly, yes, as Zach said, on the revenue growth and the market growth, we're assuming – we're expecting it would stay in the low single digits going forward.

Thank you.

That's very helpful. And then just the final question, just I guess – Related to that as well, just on the RISE Rewards Program, now that you have some more time with that, anything you can share in terms of how the rollout is occurring relative to your expectations and any data points regarding members of the program, economics, et cetera? Thanks.

Thanks for the question, Federico. We're still early days. We're just several months into this launch, but it is tracking quite well. The engagement we're getting from loyalty members is extremely strong. We're excited to roll out a similar and parallel program for our liquor business in the coming quarters. and think that there will be an interesting opportunity and some very rich data that we can receive from that. We're going to update the market on this program, but wanted to get a couple quarters of performance underneath our belt before sharing more detailed stats.

Thank you very much.

Thank you. This concludes the Q&A session for today. I would like to turn the call back over to Zach George for closing remarks.

Please go ahead. Thanks all for joining us today. I appreciate your support, and we look forward to updating you on our progress in the near future. Thank you. This concludes today's conference call. You may disconnect your line. Thank you for participating. And have a pleasant day.